Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)

AIMS: The MRC RT01 trial used conformal radiotherapy to the prostate, a method that reduces the volume of normal tissue treated by 40–50%. Because of the risk of geographical miss, the trial used portal imaging to examine whether treatment delivery was within the required accuracy. MATERIAL AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanley, S., Griffiths, S., Sydes, M.R., Moore, A.R., Syndikus, I., Dearnaley, D.P.
Formato: Texto
Lenguaje:English
Publicado: W.B. Saunders 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568874/
https://www.ncbi.nlm.nih.gov/pubmed/18565744
http://dx.doi.org/10.1016/j.clon.2008.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568874/
https://www.ncbi.nlm.nih.gov/pubmed/18565744
http://dx.doi.org/10.1016/j.clon.2008.04.019

Ejemplares similares